Mohammad Siddiqui, MD
Gastroenterology · Charlottesville, VANPI 1578858155
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,686 of the $15,145 with a category attached, or 97.0%. Novo Nordisk accounts for 76.9% of it on its own, with 10 other manufacturers making up the rest. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $631.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$12K
- Madrigal Pharmaceuticals$3K
- Pfizer$46
- Gilead$35
- Intra-sana Laboratories$34
- Sanofi$28
- plus $86 from 5 others
Across 63 payments — averaging $11,327 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk$387K
- Eli Lilly$191K
- Boehringer Ingelheim$57K
- Takeda Pharmaceuticals U.S.A., Inc.$40K
- AstraZeneca$33K
- Boehringer Ingelheim RCV GmbH & Co KG$5K
What the payments were for
- Consulting fees$14,68697%
- Food & beverage$4593%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $11,640 |
| Madrigal Pharmaceuticals | 3 | $3,276 |
| Pfizer | 2 | $46 |
| Gilead | 1 | $35 |
| Intra-sana Laboratories | 2 | $34 |
| Sanofi | 1 | $28 |
| QOL Medical, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Organon | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZDIFFRA$3,276
How this compares
$15,145 in reported general payments places this provider in the 90th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Envarsus XrTacrolimus | 41 | $33,674 |
| EliquisApixaban | 37 | $20,304 |
| OzempicSemaglutide | 13 | $20,167 |
| Tacrolimus | 144 | $14,319 |
| Ursodiol | 37 | $5,693 |
| Mycophenolate Mofetil | 14 | $1,934 |
| Atorvastatin Calcium | 105 | $993 |
| Gabapentin | 53 | $819 |
| Pantoprazole Sodium | 46 | $623 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $593 |
| Azathioprine | 17 | $571 |
| Lactulose | 14 | $568 |
| Omeprazole | 32 | $487 |
| Entecavir | 16 | $384 |
| Propranolol Hcl | 11 | $264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $46 | $20,30437 claims |
| Novo NordiskOzempic | $11,640 | $20,16713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 473 gastroenterology providers in Virginia.
Other gastroenterology in Charlottesville
- Bryan SauerCharlottesville$540K
- Brian WentworthCharlottesville$276K
- Vanessa ShamiCharlottesville$210K
- David PeuraCharlottesville$103K
- Esteban FigueroaCharlottesville$66K
- Amir RummanCharlottesville$31K
- Michael McCabeCharlottesville$18K
- Fabio CominelliCharlottesville$15K
- Larry ClarkLynchburg$1.2M
- Arun SanyalRichmond$855K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.